What question did this study set out to answer?

This research aims to develop a reliable method for genotyping specific IL-22 SNPs that may affect disease susceptibility.

May 21, 2026Current ProtocolsOpen Access

Sequence‐Specific Primer Polymerase Chain Reaction Genotyping of Interleukin‐22 Single Nucleotide Polymorphisms rs2227473 and rs2227513 with Validation by Sanger Sequencing

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial demonstrates fast SNP genotyping methodology in large-scale studies, indicating improved reliability.

This research aims to develop a reliable method for genotyping specific IL-22 SNPs that may affect disease susceptibility.
Protocol includes optimization of PCR conditions such as temperature and MgCl2 concentration.
Used human growth hormone gene as an internal control for validation.
Products analyzed by agarose gel electrophoresis and validated with Sanger sequencing.
Achieved complete concordance between PCR-SSP and Sanger sequencing, confirming method reliability.
Demonstrated a cost-effective and reproducible approach for SNP genotyping suitable for large studies.

Schavaren et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark